October 4, 2012
October 4, 2012 —
At the University of California, San Diego, two University of California, San Diego scientists have received a $1 million grant from the W.M. Keck Foundation to fund research into exploring a molecular approach to delivering drugs into cells that could change the pharmaceutical industry worldwide. The W.M. Keck Foundation of Los Angeles supports “high risk/high reward” pioneering discoveries in groundbreaking studies that enable researchers to translate their innovative ideas into real world impact.
October 4, 2012
October 4, 2012 —
“I felt like I was making a difference when I was interning at UC San Diego, but now I feel like my work is making a global difference” said University of California, San Diego alum Ahmina Ahmad, whose green job experience at UC San Diego helped her win her current position with the environment and conservation department at Walt Disney Company.
October 3, 2012
October 3, 2012 —
UC San Diego Sulpizio Cardiovascular Center has been named one of the nation’s 50 Top Cardiovascular Hospitals by Truven Health Analytics. The Truven study examined the performance of more than 1,000 hospitals by analyzing outcomes for patients with heart failure and heart attacks and for those who received coronary bypass surgery and percutaneous coronary interventions such as angioplasties.
October 3, 2012
October 3, 2012 —
Researchers at the University of California, San Diego School of Medicine report the discovery of microbial–dependent mechanisms through which some cancers mount an inflammatory response that fuels their development and growth.
October 3, 2012
October 3, 2012 —
Briana Bilbray is only 25, yet she is undergoing the fight of her life—against melanoma. In addition to waging a battle against the disease, Briana is also working to raise awareness of the risks of melanoma, particularly among young people.
October 2, 2012
October 2, 2012 —
The University of California, San Diego division of the California Institute for Telecommunications and Information Technology (Calit2) has given the green light to 17 new projects funded through the Calit2 Strategic Research Opportunities (CSRO) program. All told, the winning proposals garnered more than $826,000 in support from Calit2 for the year-long projects, effective October 1, 2012.
October 1, 2012
October 1, 2012 —
Two proteins previously found to contribute to ALS, also known as Lou Gehrig’s disease, have divergent roles. But a new study, led by researchers at the Department of Cellular and Molecular Medicine at the University of California, San Diego School of Medicine, shows that a common pathway links them.
September 27, 2012
September 27, 2012 —
An international consortium of scientists studying chronic lymphocytic leukemia (CLL), based at the University of California, San Diego School of Medicine, has been awarded a 5-year, $20 million grant by the National Cancer Institute, part of the National Institutes of Health. The grant is the second renewal of funding for a broad-based effort designed to better understand the pathology of CLL – the most common form of leukemia in the Western world – and develop new drugs and treatments.
September 27, 2012
September 27, 2012 —
Atherosclerosis has been presumed to be the consequence of complicated interactions between overabundant cholesterol and resulting inflammation in the heart and blood vessels. Researchers at the University of California, San Diego School of Medicine, with colleagues at institutions across the country, say the relationship is not exactly what it appears, and that a precursor to cholesterol actually suppresses inflammatory response genes. This precursor molecule could provide a new target for drugs designed to treat atherosclerosis.
September 27, 2012
September 27, 2012 —
Researchers at the University of California, San Diego School of Medicine have found that recovery from an emerging, minimally invasive surgical technique called Laparo-Endoscopic Single-Site Surgery (LESS) was less painful for kidney cancer patients than traditional laparoscopic surgery.
